carnitine has been researched along with tamoxifen in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 10 (62.50) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Adamopoulos, DA; Andreou, E; Kapolla, N; Karamertzanis, M; Nicopoulou, S | 1 |
| Ali-vehmas, T; Atroshi, F; Rizzo, A; Westermarck, T | 1 |
| Dalessandri, KM | 1 |
| Kroup, M; Noorafshan, A; Shirazi, M; Tanideh, N | 1 |
| Larsen, SM; Levine, LA | 1 |
| Chen, XF; Dai, JC; Li, Z; Ping, P; Shang, XJ; Zhang, FB | 1 |
| El-Ashmawy, NE; Khalil, RM | 1 |
| Abu El Nour, SM; Eissa, AA; Ibrahim, AB; Mansour, HH; Shouman, SA | 1 |
| Carson, CC; Jordan, GH; Lipshultz, LI | 1 |
| Al Saied, AE; El Taieb, MA; Ibrahim, HM; Nada, EA | 1 |
| Chang, XL; Li, JD; Li, W; Teng, ZH; Wang, YX; Yang, SW; Zhang, H; Zhang, YP | 1 |
| Caudal, A; Kolwicz, SC; McMillen, TS; Ritterhoff, J; Senn, T; Tian, R; Villet, O; Young, S | 1 |
3 review(s) available for carnitine and tamoxifen
| Article | Year |
|---|---|
Peyronie's disease: review of nonsurgical treatment options.
Topics: 4-Aminobenzoic Acid; Calcium Channel Blockers; Carnitine; Colchicine; Collagenases; Combined Modality Therapy; Contraindications; Electroconvulsive Therapy; Humans; Interferons; Iontophoresis; Male; Penile Induration; Pentoxifylline; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Tamoxifen; Traction; Vitamin E | 2011 |
A review on the role of L-carnitine in the management of tamoxifen side effects in treated women with breast cancer.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Carnitine; Female; Humans; Insulin-Like Growth Factor I; Nitric Oxide; Receptor, ErbB-2; Tamoxifen | 2014 |
Minimally invasive treatment of Peyronie's disease: evidence-based progress.
Topics: 4-Aminobenzoic Acid; Administration, Oral; Calcium Channel Blockers; Carnitine; Colchicine; Evidence-Based Medicine; Humans; Injections, Intralesional; Interferon-alpha; Iontophoresis; Lithotripsy; Male; Microbial Collagenase; Nicardipine; Penile Induration; Phosphodiesterase Inhibitors; Randomized Controlled Trials as Topic; Tamoxifen; Treatment Outcome; Verapamil; Vitamin E | 2014 |
2 trial(s) available for carnitine and tamoxifen
| Article | Year |
|---|---|
The combination of testosterone undecanoate with tamoxifen citrate enhances the effects of each agent given independently on seminal parameters in men with idiopathic oligozoospermia.
Topics: Acrosin; Adult; Aniline Compounds; Carnitine; Cohort Studies; Drug Synergism; Drug Therapy, Combination; Estrogen Antagonists; Humans; Male; Middle Aged; Oligospermia; Prospective Studies; Sperm Count; Sperm Motility; Spermatozoa; Tamoxifen; Testosterone; Testosterone Congeners; Time Factors | 1997 |
[Efficacy of natural vitamin E on oligospermia and asthenospermia: a prospective multi-centered randomized controlled study of 106 cases].
Topics: Adult; Asthenozoospermia; Carnitine; Female; Humans; Male; Middle Aged; Oligospermia; Pregnancy; Pregnancy Rate; Prospective Studies; Tamoxifen; Treatment Outcome; Vitamin E; Young Adult | 2012 |
11 other study(ies) available for carnitine and tamoxifen
| Article | Year |
|---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Effects of tamoxifen, melatonin, coenzyme Q10, and L-carnitine supplementation on bacterial growth in the presence of mycotoxins.
Topics: Aflatoxin B1; Antineoplastic Agents, Hormonal; Antioxidants; Bacteria; Carboxylic Acids; Carnitine; Cell Division; Coenzymes; Dose-Response Relationship, Drug; Erysipelothrix; Escherichia coli; Fumonisins; Lacticaseibacillus casei; Lactobacillus; Melatonin; Mycotoxins; Ochratoxins; Salmonella; Staphylococcus aureus; Streptococcus agalactiae; T-2 Toxin; Tamoxifen; Trichothecenes; Ubiquinone; Yersinia enterocolitica | 1998 |
Multiple Methods for Reduction of Lipoprotein(a).
Topics: Ascorbic Acid; Carnitine; Coronary Artery Disease; Diet, Reducing; Estrogens; Exercise; Female; Humans; Hyperlipoproteinemia Type II; Lipoprotein(a); Mutation; Niacin; Receptors, LDL; Risk Factors; Tamoxifen | 2002 |
Comparison of the effects of captopril, tamoxifen and L-carnitine on renal structure and fibrosis after total unilateral ureteral obstruction in the rat.
Topics: Animals; Captopril; Carnitine; Female; Fibrosis; Kidney; Rats; Rats, Sprague-Dawley; Tamoxifen; Ureteral Obstruction | 2007 |
Modulatory effects of L-carnitine on tamoxifen toxicity and oncolytic activity: in vivo study.
Topics: Animals; Carcinoma, Ehrlich Tumor; Carnitine; DNA Fragmentation; Drug Interactions; Female; Lipid Peroxides; Liver; Mice; Neoplasms, Experimental; Nitrogen Oxides; Oxidative Stress; Random Allocation; Rats; Superoxide Dismutase; Tamoxifen; Uterus | 2014 |
Efficacy of tamoxifen and l-carnitine on sperm ultrastructure and seminal oxidative stress in patients with idiopathic oligoasthenoteratozoospermia.
Topics: Adult; Asthenozoospermia; Carnitine; Humans; Male; Malondialdehyde; Microscopy, Electron, Transmission; Oxidative Stress; Reactive Oxygen Species; Semen; Semen Analysis; Spermatozoa; Tamoxifen | 2015 |
[Efficacy of alpha-lipoic acid combined with tamoxifen citrate in the treatment of oligoasthenospermia].
Topics: Antioxidants; Asthenozoospermia; Biomarkers; Carnitine; Drug Therapy, Combination; Female; Humans; Male; Oligospermia; Oxidative Stress; Pregnancy; Pregnancy Rate; Semen Analysis; Sperm Count; Sperm Motility; Spermatozoa; Tamoxifen; Thioctic Acid | 2017 |
Increasing fatty acid oxidation elicits a sex-dependent response in failing mouse hearts.
Topics: Acetyl-CoA Carboxylase; Animals; Carnitine; Disease Models, Animal; Energy Metabolism; Fatty Acids; Female; Gene Deletion; Heart Failure; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardium; Oxidation-Reduction; PPAR alpha; Sex Factors; Signal Transduction; Tamoxifen | 2021 |